article thumbnail

Stelara for psoriasis: Dosage, efficacy & more

The Checkup by Singlecare

The subcutaneous dosage of Stelara for psoriasis is as follows: For adults with psoriasis who weigh 220 pounds or less: The first dose is 45 mg. The dosage for pediatric patients (6 to 17 years of age) is based on weight. Avoid live vaccines while taking Stelara. It can be self-injected into the buttocks, thigh, or abdomen.

Dosage 98
article thumbnail

The mRNA-1273 Vaccine at 25-?g Dosage May Protect Infants, Young Children Against Omicron

Pharmacy Times

The Moderna mRNA-1273 vaccine was found to be effective for more than 50% of children aged 6 to 23 months.

Dosage 65
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Brazil grants authorisation for Sinovac’s Covid-19 vaccine in children

Pharmaceutical Technology

The Brazilian Health Regulatory Agency (Anvisa) has granted emergency use authorization for Sinovac Biotech’s Covid-19 vaccine, CoronaVac, in children aged three to five years. Subjects in this age group can receive the same vaccine dosage authorised in patients aged six to 17 years, as well as adults.

article thumbnail

Health Canada authorises Pfizer-BioNTech’s Covid-19 vaccine for children

Pharmaceutical Technology

Health Canada has granted authorisation for Pfizer ’s unit Pfizer Canada and BioNTech’s Covid-19 vaccine, Comirnaty, as a three 3?g This dosage was chosen as the preferred dose in children aged under five years based on safety, tolerability and immunogenicity findings. g paediatric vaccine doses following the authorisation.

article thumbnail

Pfizer and BioNTech seek FDA EUA for Omicron-based Covid-19 vaccine

Pharmaceutical Technology

Pfizer and BioNTech have filed an application seeking Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a booster dosage of an Omicron BA.4/BA.5-adapted 5-adapted bivalent vaccine for Covid-19 in people aged 12 years and above. 1-adapted vaccine. 5-adapted bivalent vaccine.

article thumbnail

UK MHRA approves Pfizer-BioNTech’s bivalent Covid-19 booster

Pharmaceutical Technology

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pfizer and BioNTech’s bivalent Covid-19 booster vaccine that targets the SARS-CoV-2 virus’ original strain and the Omicron BA.4 Each booster dosage contains 15?g 1 vaccine as well as the safety results from a clinical trial underway. 5 sub-variants.

Vaccines 105
article thumbnail

AZ mulls trial of new COVID-19 vaccine dose as UK regulator begins review

pharmaphorum

AstraZeneca is to run an additional global trial to test its COVID-19 vaccine at a lower dosage, as the UK regulator begins to review trial data. Health secretary Matt Hancock has asked the UK’s regulator the Medicines and Healthcare products Regulatory Agency (MHRA) to begin its review of the vaccine.